Part D/Prescription Drugs

EpiPen Recall

On Friday, Mylan NV said that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply